Form 4: Acrivon Therapeutics Officer Sells Shares for Tax
Insider Transaction Report
Acrivon Therapeutics' Chief Legal Officer, Mary Miller, disposed of 284 shares of common stock to cover tax obligations related to restricted stock unit vesting.
Summary
- Mary Miller, Chief Legal Officer of Acrivon Therapeutics, Inc. (ACRV), reported a transaction on October 1, 2025.
- The transaction involved the disposition of 284 shares of common stock.
- These shares were withheld by the Issuer to satisfy mandatory tax withholding requirements upon the vesting of restricted stock units.
- The shares were disposed of at a price of $1.81 per share.
- Following this transaction, Mary Miller beneficially owns 35,297 shares of Acrivon Therapeutics common stock directly.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax withholding, which is a neutral event and does not indicate positive or negative sentiment towards the company's performance or outlook.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing details a routine insider transaction for tax withholding purposes and does not provide information relevant to broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes by an insider.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of transaction (disposition of shares). |
| 10/03/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
SEC Form 4, Insider Transaction, Acrivon Therapeutics, ACRV, Stock Sale, Tax Withholding, Restricted Stock Units, Chief Legal Officer, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.